Company
IanTrek
New Bio-intervention™ surgical category using natural allogeneic biotissue and micro-interventional technology.
Also known as Iantrek, Inc.
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Headquarters
- White Plains, NY, United States
- Customers
- healthcare professionals and their patients who need it most
- Legal name
- Iantrek, Inc.
- iantrekmed.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Harnessing the intrinsic power of natural allogeneic biotissue and applying high-precision micro-interventional technology, we have created a new surgical category of Bio-intervention™ which can impact and reimagine conventional surgical paradigms.
Funding snapshot
- Total raised
- $58.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series C, $42M2025-08-20
Funding rounds
- Round, 2025
- $34.7M2025-08-19, SEC form D sold, 21 investors
- Round, 2025
- $2.8M2025-02-14, SEC form D sold, 4 investors
- Round, 2022
- $15.4M2022-08-04, SEC form D sold, 25 investors
- Round, 2020
- $5.2M2020-10-16, SEC form D sold, 29 investors
Products
- Other
- AlloFlo Uveo
- Web
- AlloFlo™ Uveo
- Other
- AlloSert Uveo
- Web
- AlloSert™ Uveo
- Other
- C-Rex
- Web
- C-Rex
- Web
- C-Rex Duo
- Web
- Project Erie
Loading relationship preview